Requests that the FDA Admit "Waste Parity" Status: Formally acknowledge that the active estrogenic metabolites used in approved conjugated equine estrogen (CEE) pharmaceuticals (such as Premarin) are molecularly identical to the raw equine metabolites the Agency classifies as prohibited "filth" under Section 402(a)(3) of the FD&C Act
🏛 Food and Drug Administration (FDA)FDA-2026-P-6279
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.